The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Originally identified in Drosophila melanogaster, the Warts(Wts)/Lats protein kinase has been proposed to function with two other Drosophila proteins, Hippo (Hpo) and Salvador (Sav), in the regulation of cell cycle exit and apoptosis. In mammals, two candidate Warts/Lats homologs, termed Lats1 and Lats2, have been described, and the targeted disruption of LATS1 in mice increases tumor formation. Little, however, is known about the function and regulation of human Lats kinases. Here we report that human Mst2, a STE20-family member and purported Hpo ortholog, phosphorylates and activates both Lats1 and Lats2. Deletion analysis revealed that regulation of Lats1 occurs through the C-terminal, catalytic domain. Within this domain, two regulatory phosphorylation sites were identified by mass spectrometry. These sites, S909 in the activation loop and T1079 within a hydrophobic motif, have been highly conserved during evolution. Moreover, a direct interaction was observed between Mst2 and hWW45, a putative ortholog of Drosophila Sav. These results indicate that Mst2-like kinases regulate Lats kinase activities in an evolutionarily conserved regulatory pathway. Although the function of this pathway remains poorly understood in mammals, it is intriguing that, in Drosophila, it has been linked to development and tissue homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, LATS1 requires phosphorylation to be active [105] and LATS1 phosphorylation was increased on the non-acetylated, less stable LATS1K751R [104].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [105]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P., Halladay, J., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,637
Active and Inactive Protein Kinases: Structural Basis for Regulation
Johnson, L. N., Noble, M. E. M., & Owen, D. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81092-2 · Cited by 1,403 · cited 2×
“Interestingly, these sites are located within the activation loop (S909) and a hydrophobic motif (T1079), two domains previously been implicated in the activation of other kinases (Johnson et al., 1996; Tamaskovic et al., 2003).”
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,387
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098 · cited 10×
“When expressed in Drosophila, Mst2 was able to rescue the hpomutant phenotype, showing that it can act as a functional ortholog (Wu et al., 2003).”
BackgroundResultInfluentialDammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis
Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 976 · cited 7×
“These data suggested that Wts/Lats, Sav and Hpo might form a trimeric complex in which Sav functions as an adaptor protein to bring Wts/Lats in close proximity to Hpo (Harvey et al., 2003).”
BackgroundResultInfluentialTapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856 · cited 7×
“…neither the N-terminally located putative UBA domain, a structure believed to bind ubiquitin moieties (Buchberger, 2002), nor the PPXY motifs, previously implicated in mediating the interaction between Wts/lats and Sav in Drosophila (Tapon et al., 2002), were required for this regulation.”
BackgroundResultInfluentialXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Cited by
Items 101–200 of 604
Kudryashova, T. V., Goncharov, D. A., Pena, A. Z., Kelly, N. J., Vanderpool, R. R., Baust, J., Kobir, A., Shufesky, W. J., Mora, A. L., Morelli, A. E., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2003oc · Cited by 143
“HIPPO is comprised of Ste20-like proteinkinases (MST) 1/2 that activate large tumor suppressors (LATS) 1/2 by phosphorylation at T1079 (9).”
BackgroundInfluentialSelf-citationQuantitative Analysis Reveals that Actin and Src-Family Kinases Regulate Nuclear YAP1 and Its Export
Ege, N., Dowbaj, A. M., Jiang, M., Howell, M., Hooper, S., Foster, C., Jenkins, R. P., & Sahai, E. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.006 · Cited by 131
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
Ho, K. C., Zhou, Z., She, Y.-M., Chun, A., Cyr, T. D., & Yang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101273108 · Cited by 134
Lats2 Is a Negative Regulator of Myocyte Size in the Heart
Matsui, Y., Nakano, N., Shao, D., Gao, S., Luo, W., Hong, C., Zhai, P., Holle, E., Yu, X., Yabuta, N., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.180042 · Cited by 131
SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK
Bae, S. J., Ni, L., Osinski, A., Tomchick, D. R., Brautigam, C. A., & Luo, X. (2017) · eLife · doi:10.7554/elife.30278 · Cited by 132
“Activated MST1/2 partner with SAV1 to phosphorylate and activate the LATS1/2–MOB1 complexes (Chan et al., 2005; Praskova et al., 2008), which in turn phosphorylate and inactivate the oncogenic transcriptional co-activators YAP/TAZ Bae et al. eLife 2017;6:e30278.”
BackgroundNDR Functions as a Physiological YAP1 Kinase in the Intestinal Epithelium
Zhang, L., Tang, F., Terracciano, L., Hynx, D., Kohler, R. S., Bichet, S., Heß, D., Cron, P. D., Hemmings, B. A., Hergovich, A., et al. (2015) · Current Biology · doi:10.1016/j.cub.2014.11.054 · Cited by 141
“MST1/2 kinases can function as upstream kinases of LATS [41] and NDR [14, 17], and hMOB1 proteins act as coactivators for both NDR [14, 17, 42–44] and LATS kinases [39, 45–47].”
BackgroundBiosignaling of mammalian Ste20-related kinases
Ling, P., Lu, T., Yuan, C.-J., & Lai, M.-D. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.019 · Cited by 140
Human LATS1 Is a Mitotic Exit Network Kinase
Bothos, J. G., Tuttle, R. L., Ottey, M., Luca, F. C., & Halazonetis, T. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0862 · Cited by 147
Development, Proliferation, and Growth of the Mammalian Heart
Günthel, M., Barnett, P., & Christoffels, V. M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.022 · Cited by 136
“When the Hippo pathway is active, the kinases mammalian sterile 20-like kinase 1 and 2 (MST1/2), which are homologous of the Drosophila Hippo kinase, form a complex with the scaffold protein Salvador (SAV), and in turn activate the large tumor suppressor homolog 1 and 2 (LATS1/2) kinases.(48,49) LATS1/2 and the Mps on…”
BackgroundDel Re, D. P., Matsuda, T., Zhai, P., Gao, S., Clark, G. J., Van Der Weyden, L., & Sadoshima, J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43569 · Cited by 126
He, J., Bao, Q., Meng, Y., Liang, J., Zhu, Y., Wang, C., & Ai, D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13806 · Cited by 130
“…protein 1, large tumour suppressor 1/2 (LATS1/2), MOB kinase activator 1A/B, mitogen-activated protein 4 kinase 4, YAP/TAZ, and transcriptional enhancer associate domain family members 1–4 (TEAD1–4) (Chan et al., 2005; Callus et al., 2006; Hao et al., 2008; Lei et al., 2008; Zhao et al., 2008).”
BackgroundInfluentialWWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy
Qi, S., Zhu, Y., Liu, X., Li, P., Wang, Y., Zeng, Y. J., Yu, A., Wang, Y., Sha, Z., Zhong, Z., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.027 · Cited by 125
On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology
Shao, Y., Sang, J., & Fu, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.078 · Cited by 110
“Other than MST1/2, Lats1/2 can also be activated through binding scaffold proteins MOBKL1A/B (Mob1) [118], making the upstream kinase MST1/2 functionally redundant in some cases.”
BackgroundInfluence of human Ect2 depletion and overexpression on cleavage furrow formation and abscission
Chalamalasetty, R. B., Hümmer, S., Nigg, E. A., & Silljé, H. H. W. (2006) · Journal of Cell Science · doi:10.1242/jcs.03032 · Cited by 114
“The plasmid containing the hWW45 cDNA has been described before (Chan et al., 2005).”
BackgroundSelf-citationLats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation
Zhang, K., Rodríguez-Aznar, E., Yabuta, N., Owen, R. J., Mingot, J. M., Nojima, H., Nieto, M. A., & Longmore, G. D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.357 · Cited by 128
“Manipulation of the Hippo (Mst1/2) kinase, by over-expression or cell–cell contact results in Lats2 activation (Chan et al , 2005) and Snail1 phosphorylation and stabilization.”
Feng, X., Liu, P., Zhou, X., Li, M.-T., Li, F.-L., Wang, Z., Meng, Z., Sun, Y.-P., Yu, Y., Xiong, Y., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739722 · Cited by 119
“The phosphorylation of the activation loop (Ser-909/Ser-872 for LATS1/2) and hydrophobic motif (Thr-1079/Thr-1041 for LATS1/2) correlates with LATS1/2 kinase activity (46).”
BackgroundRole of the Hippo Pathway in Fibrosis and Cancer
Kim, C.-L., Choi, S.-H., & Mo, J. (2019) · Cells · doi:10.3390/cells8050468 · Cited by 119
Chiba, S., Ikeda, M., Katsunuma, K., Ohashi, K., & Mizuno, K. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.054 · Cited by 118
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer
Mohajan, S., Jaiswal, P. K., Vatanmakarian, M., Yousefi, H., Saikolappan, S., Alahari, S. K., Koul, S., & Koul, H. K. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.006 · Cited by 116
Shedding light on Merlin's wizardry
Okada, T., You, L., & Giancotti, F. G. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.03.006 · Cited by 117
A Regulation Loop between YAP and NR4A1 Balances Cell Proliferation and Apoptosis
He, L., Yuan, L., Yu, W., Sun, Y., Jiang, D., Wang, X., Feng, X., Wang, Z., Xu, J., Yang, R., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108284 · Cited by 118
Hergovich, A., Kohler, R. S., Schmitz, D., Vichalkovski, A., Cornils, H., & Hemmings, B. A. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.020 · Cited by 115
Mechanisms of Growth and Homeostasis in the Drosophila Wing
Neto-Silva, R. M., Wells, B. S., & Johnston, L. A. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175242 · Cited by 121
“Mammalian orthologs of each of the core components of the Hpo/Wts pathway exist and can functionally replace their respective Drosophila counterparts, and their mutations are associated with tumorigenesis in mammals (Chan et al. 2005, Tamaskovic et al. 2003).”
BackgroundZheng, Y., Liu, B., Wang, L., Lei, H., Pulgar Prieto, K. D., & Pan, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.076 · Cited by 110
“, 2016); FLAG-MST2, FLAG-MST2D164A (Chan et al., 2005); Flag-Hpo, and GST-Mats (Ni et al.”
BackgroundRegulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling
Hergovich, A. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-32 · Cited by 113
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
Azad, T., Ghahremani, M., & Yang, X. (2019) · Cells · doi:10.3390/cells8050407 · Cited by 116
The Roles of NDR Protein Kinases in Hippo Signalling
Hergovich, A. (2016) · Genes · doi:10.3390/genes7050021 · Cited by 105
“MST1/2 also phosphorylate LATS1/2 on their respective hydrophobic motif regulatory sites [19], which is important for LATS1/2 activation [19,86,87].”
BackgroundHerding Hippos: regulating growth in flies and man
Badouel, C., Garg, A., & McNeill, H. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.09.010 · Cited by 114
Merlin Is a Potent Inhibitor of Glioma Growth
Lau, Y.-K. I., Murray, L. B., Houshmandi, S. S., Yin, X., Gutmann, D. H., & Yu, Q. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0190 · Cited by 111
“MST1 and MST2 can phosphorylate and activate Lats1 and Lats2 (36).”
BackgroundInfluentialRegulation of organ size: Insights from the Drosophila Hippo signaling pathway
Kango‐Singh, M., & Singh, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21996 · Cited by 101
“Mst1 and 2 phosphorylate (a) Lats1/2 on the activation loop and hydrophobic motif (Chan et al., 2005), (b) WW45 after physically interacting (binding) with WW45 (Callus et al.”
BackgroundHeat stress activates YAP/TAZ to induce the heat shock transcriptome
Luo, M., Meng, Z., Moroishi, T., Lin, K. C., Shen, G., Mo, F., Shao, B., Wei, X., Zhang, P., Wei, Y., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00602-9 · Cited by 112
Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ
Kwon, H., Kim, J.-Y., & Jho, E. (2021) · FEBS Journal · doi:10.1111/febs.16091 · Cited by 117
A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis
Shen, S., Guo, X., Yan, H., Lu, Y., Ji, X., Li, L., Liang, T., Zhou, D., Feng, X.-H., Zhao, J. C., et al. (2015) · Cell Research · doi:10.1038/cr.2015.98 · Cited by 103
Targeting YAP and Hippo signaling pathway in liver cancer
Liu, A. M., Xu, Z., Chen, J., Poon, R. T. P., & Luk, J. M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.499361 · Cited by 104
“Suppression of SAV1 has been found to inhibit MST1 mediated apoptosis [101].”
BackgroundInfluentialJeon, S., Jeon, Y., Lim, J.-Y., Kim, Y., Cha, B., & Kim, W. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02070-1 · Cited by 118
Hippo‐YAP signaling pathway: A new paradigm for cancer therapy
Ma, Y., Yang, Y., Wang, F., Wei, Q., & Qin, H. (2014) · International Journal of Cancer · doi:10.1002/ijc.29073 · Cited by 104
“In the Hippo kinase cascade, Mst1/2 phosphorylates Lats1/2 through their SARAH coiled-coil domains.(76) It also phosphorylates Mob1, which enhances Mob1’s ability to bind and activate Lats1/2.”
BackgroundOxidative stress–CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway
Jin, J., Zhang, L., Li, X., Xu, W., Yang, S., Song, J., Zhang, W., Zhan, J., Luo, J., & Zhang, H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac189 · Cited by 99
Mechanosensing in macrophages and dendritic cells in steady-state and disease
Lee, M., Du, H., Winer, D. A., Clemente-Casares, X., & Tsai, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1044729 · Cited by 99
The Emerging Role of YAP/TAZ in Tumor Immunity
Pan, Z., Tian, Y., Cao, C., & Niu, G. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0375 · Cited by 94
Wennmann, D. O., Vollenbröker, B., Eckart, A. K., Bonse, J., Erdmann, F., Wolters, D. A., Schenk, L. K., Schulze, U., Kremerskothen, J., Weide, T., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.476 · Cited by 102
Mana‐Capelli, S., & McCollum, D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004187 · Cited by 105
“Results Angiomotins promote LATS1/2 activation Phosphorylation at the LATS2-HM site is presumed to be the primary regulatory site for LATS1/2 because, when phosphorylated, it promotes autophosphorylation in the activation loop (AL) of the kinase to make it fully active (6,10,11), allowing it to phosphorylate YAP and o…”
BackgroundInfluentialLATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
Gan, W., Dai, X., Dai, X., Xie, J., Yin, S., Zhu, J., Wang, C., Liu, Y., Guo, J., Wang, M., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0463-6 · Cited by 98
YAP and TAZ Take Center Stage in Cancer
Zhang, K., Qi, H.-X., Hu, Z., Chang, Y., Shi, Z., Han, X., Han, Y., Zhang, R., Zhang, Z., Chen, T., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01014 · Cited by 100
Negative regulation of Yap during neuronal differentiation
Zhang, H., Deo, M., Thompson, R. C., Uhler, M. D., & Turner, D. L. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.10.017 · Cited by 100
“Similarly, probable autophosphorylation of the activation loop of human Lats1/2 at S909/S872 reflects Lats1/2 kinase activity (Chan et al., 2005; Praskova et al., 2008; Zhou et al., 2009).”
Mst1 and Mst2 kinases: regulations and diseases
Qin, F., Tian, J., Zhou, D., & Chen, L. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-31 · Cited by 103
“Sav binds both Hippo and Warts, and promotes Hippo phosphorylation of Warts; Mats is another Hippo substrate that binds to and promotes Warts activation.”
BackgroundInfluentialFramework to function: mechanosensitive regulators of gene transcription
Finch-Edmondson, M., & Sudol, M. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0028-7 · Cited by 93
“Triggered by various upstream stimuli, for example cell-cell contact [55], the MST1/2 kinases together with the adaptor protein SAV1 (WW45) phosphorylate and activate LATS1/2 and MOB [56, 57].”
BackgroundPefani, D., Latusek, R., Pires, I. M., Grawenda, A. M., Yee, K. S. Y., Hamilton, G., van der Weyden, L., Esashi, F., Hammond, E. M., & O’Neill, E. E. (2014) · Nature Cell Biology · doi:10.1038/ncb3035 · Cited by 97
MST1/MST2 Protein Kinases: Regulation and Physiologic Roles
Galan, J. A., & Avruch, J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00763 · Cited by 98
Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity
Kim, N., & Gumbiner, B. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819400116 · Cited by 97
Size control: the developmental physiology of body and organ size regulation
Gokhale, R. H., & Shingleton, A. W. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.181 · Cited by 108
The Hippo signal transduction network in skeletal and cardiac muscle
Wackerhage, H., Del Re, D. P., Judson, R. N., Sudol, M., & Sadoshima, J. (2014) · Science Signaling · doi:10.1126/scisignal.2005096 · Cited by 92
Wilson, K. E., Li, Y.-W., Yang, N., Shen, H., Orillion, A. R., & Zhang, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534701 · Cited by 92
“In addition, the upstream MST proteins are important for LATS1 Thr(1079) phosphorylation (28, 29).”
BackgroundMokhtari, R. B., Ashayeri, N., Baghaie, L., Sambi, M., Satari, K., Baluch, N., Bosykh, D. A., Szewczuk, M. R., & Chakraborty, S. (2023) · Cancers · doi:10.3390/cancers15133468 · Cited by 100
Regulation of mammalian Ste20 (Mst) kinases
Rawat, S. J., & Chernoff, J. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.01.001 · Cited by 91
“In mammals, Mst1/2, in conjunction with WW45, phosphorylates Mob1 and Lats1/2, leading to their activation [10, 11].”
BackgroundHua, K., Jin, J., Zhao, J., Song, J., Song, H., LI, D., Maskey, N., Zhao, B., Wu, C., Xu, H., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3405 · Cited by 90
The Hippo pathway in chemotherapeutic drug resistance
Zhao, Y., & Yang, X. (2015) · International Journal of Cancer · doi:10.1002/ijc.29293 · Cited by 86
“Once MST1/2 is activated by autophosphorylation on two threonine residues (T180/183), it subsequently phosphorylates downstream LATS kinases, which can further phosphorylate and inhibit downstream YAP and TAZ oncogenic functions.(4,35) Down-regulation of MST has been found in hepatocarcinoma and other types of cancers.”
BackgroundThe Hippo Pathway in Prostate Cancer
Salem, O., & Hansen, C. G. (2019) · Cells · doi:10.3390/cells8040370 · Cited by 102
Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
Juan, W., & Hong, W. (2016) · Genes · doi:10.3390/genes7090055 · Cited by 85
“When the Hippo pathway is activated, MST1/2 activate LATS1/2 and MOB1A/1B by phosphorylation [11].”
BackgroundYAP-mediated mechanotransduction determines the podocyte’s response to damage
Rinschen, M. M., Grahammer, F., Hoppe, A.-K., Kohli, P., Hagmann, H., Kretz, O., Bertsch, S., Höhne, M., Göbel, H., Bartram, M. P., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf8165 · Cited by 90
Diep, C. H., Zucker, K. M., Hostetter, G., Watanabe, A., Hu, C., Munoz, R. M., Von Hoff, D. D., & Han, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032783 · Cited by 87
Activation mechanisms of the Hippo kinase signaling cascade
Bae, S. J., & Luo, X. (2018) · Bioscience Reports · doi:10.1042/bsr20171469 · Cited by 92
Emerging role of Hippo pathway in gastric and other gastrointestinal cancers
Kang, W., Cheng, A. S. L., Yu, J., & To, K. F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1279 · Cited by 91
Nore1 and RASSF1 Regulation of Cell Proliferation and of the MST1/2 Kinases
Avruch, J., Praskova, M. D., Ortiz-Vega, S., Liu, M., & Zhang, X. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07025-4 · Cited by 92
Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway
Liu, G., Yu, F.-X., Kim, Y. C., Meng, Z., Naipauer, J., Looney, D. J., Liu, X., Gutkind, J. S., Mesri, E. A., & Guan, K.-L. (2015) · Oncogene · doi:10.1038/onc.2014.281 · Cited by 81
Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer
Sharma, A., Mir, R., & Galande, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.681053 · Cited by 101
Hippo signalling in the G2/M cell cycle phase: Lessons learned from the yeast MEN and SIN pathways
Hergovich, A., & Hemmings, B. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.04.001 · Cited by 92
“RASSF1A can form complexes with MST1/2 and WW45 through conserved SARAH domains [71,82,83,111], which seems to play a role in Hippo dependent and independent apoptotic signalling [112].”
BackgroundThe Hippo pathway in colorectal cancer
Wierzbicki, P., & Rybarczyk, A. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2015.0015 · Cited by 86
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82
Mammalian Hippo signalling: a kinase network regulated by protein–protein interactions
Hergovich, A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110619 · Cited by 87
Lu, T., Lai, W.-Y., Huang, C. F., Hsieh, W.-J., Yu, J., Hsieh, Y., Chang, W., Leu, T., Chang, W., Chuang, W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605035200 · Cited by 82
Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation
Meng, F., Zhou, R., Wu, S., Zhang, Q., Jin, Q., Zhou, Y., Plouffe, S. W., Liu, S., Song, H., Xia, Z., et al. (2016) · Genes & Development · doi:10.1101/gad.277533.116 · Cited by 88
“4F) even though Mst1 was known for weak interaction with its substrates (Chan et al. 2005).”
BackgroundMammalian NDR/LATS protein kinases in hippo tumor suppressor signaling
Hergovich, A., & Hemmings, B. A. (2009) · BioFactors · doi:10.1002/biof.47 · Cited by 91
The emerging role of Hippo signaling in neurodegeneration
Sahu, M. R., & Mondal, A. C. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24551 · Cited by 78
“Studies have shown that LATS1/2 also coor‐ dinates with the effectors of the proapoptotic pathway.”
BackgroundInfluentialExpression of hippo pathway in colorectal cancer
Zhang, C., Liang, K., Zhou, G., Zhang, Q., & Li, J. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.133025 · Cited by 78
“The phosphorylation of LATS2 is enhanced by SAV1 (defined as the adaptor protein, also called hWW45 in human beings), which combines with MST1 and LATS2 through the SARAH domain of MST1 and PPXY motifs of LATS2, respectively.[10] Zhou[6,11] confirmed that MST1 is required for tumorigenesis suppression by knockdown of…”
BackgroundThe role of the Hippo pathway in the pathogenesis of inflammatory bowel disease
Xie, Z., Wang, Y., Yang, G., Han, J., Zhu, L., Li, L., & Zhang, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03395-3 · Cited by 84
Cornils, H., Kohler, R. S., Hergovich, A., & Hemmings, B. A. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15826 · Cited by 81
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Lü, T., Li, Z., Yang, Y., Ji, W., Yu, Y., Niu, X., Zeng, Q., Xia, W., & Lu, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.015 · Cited by 82
The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation
Liu, H., Jiang, D., Chi, F., & Zhao, B. (2012) · Protein & Cell · doi:10.1007/s13238-012-2919-3 · Cited by 80
Mammalian NDR protein kinases: From regulation to a role in centrosome duplication
Hergovich, A., Cornils, H., & Hemmings, B. A. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.07.017 · Cited by 83
“hWW45, MST1/2, and LATS1 (the human relatives of Drosophila Sav, Hpo, and Lats, respectively) have been reported to form a complex [12,27,28].”
BackgroundWang, H., Yu, H., Huang, T., Wang, B., & Xiang, L. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.12.012 · Cited by 80
Ski regulates Hippo and TAZ signaling to suppress breast cancer progression
Rashidian, J., Le Scolan, E., Ji, X., Zhu, Q., Mulvihill, M. M., Nomura, D., & Luo, K. (2015) · Science Signaling · doi:10.1126/scisignal.2005735 · Cited by 71
“Mst1/2 forms a complex with the adaptor protein Sav1 to phosphorylate and activate Lats1/2 (16, 17).”
BackgroundInfluentialSIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling
Xu, C. S., Jin, G., Wu, H., Cui, W., Wang, Y.-H., Manne, R. K., Wang, G., Zhang, W., Zhang, X., Han, F., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci141797 · Cited by 78
The DeMSTification of Mammalian Ste20 Kinases
Radu, M., & Chernoff, J. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.022 · Cited by 76
The characterisation of LATS2 kinase regulation in Hippo-YAP signalling
Hoa, L., Kulaberoglu, Y., Gündoğdu, R., Cook, D., Mavis, M., Gómez-Ferrer, M., Gómez, V., & Hergovich, A. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.012 · Cited by 75
The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
Hillmer, R. E., & Link, B. A. (2019) · Cells · doi:10.3390/cells8050502 · Cited by 70
Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma.
Cornils, H., Stegert, M. R., Hergovich, A., Hynx, D., Schmitz, D., Dirnhofer, S., & Hemmings, B. A. (2010) · Science Signaling · doi:10.1126/scisignal.2000681 · Cited by 72
“w are members of the nuclear Dbf2–related (NDR) family of protein kinases (4, 5).”
BackgroundMethodJansson, L., & Larsson, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032013 · Cited by 69
“Mst is stabilized by interacting with the Salvador homolog 1 (Sav1) and activates the downstream large tumor suppressor homolog 1 and 2 (Lats 1/Lats 2) via phosporylation [7].”
Polar opposites: Fine‐tuning cytokinesis through SIN asymmetry
Johnson, A. E., McCollum, D., & Gould, K. L. (2012) · Cytoskeleton · doi:10.1002/cm.21044 · Cited by 80
“The kinase(s) that phosphorylate Sid2 are unknown, but the human Sid2 homolog, LATS1, is phosphorylated and activated by the Ste20 kinase MST2 [Chan et al., 2005], implicating Cdc7 or Sid1 as candidates.”
BackgroundHippo signaling: A hub of growth control, tumor suppression and pluripotency maintenance
Yin, M.-X., & Zhang, L. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.09.009 · Cited by 77
“…their adaptors, Sav (also called WW45) and MOB1 (a Mats homolog), leads to the binding of YAP/TAZ to 14-3-3 phosphopeptide binding proteins and the suppression of YAP/TAZ activities in mammals (Chan et al., 2005; Callus et al., 2006; Hergovich et al., 2006; Lei et al., 2008; Praskova et al., 2008).”
BackgroundPhosphoregulation of Cbk1 is critical for RAM network control of transcription and morphogenesis
Jansen, J. M., Barry, M. F., Yoo, C. K., & Weiss, E. L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604107 · Cited by 76
“Germinal center kinases, which are related to Ste20 and other p21-activated kinases, phosphorylate this site in several cases (Chan et al., 2005; Stegert et al., 2005; Emoto et al., 2006).”
Hippo pathway in mammary gland development and breast cancer
Shi, P., Feng, J. C., & Chen, C. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu114 · Cited by 74
“The activatedMst1/2 complex directly phosphorylates the large tumor suppressor 1 and 2 (LATS1/2) [7] and MOBKL1A/B (also known as MOB1) that forms another kinase complex with LATS1/2 [5] (Fig.”
BackgroundYu, S., Cai, X., Wu, C., Wu, L., Wang, Y., Liu, Y., Yu, Z., Qin, S., Ma, F., Thiery, J. P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3095 · Cited by 71
“In the typical Hippo pathway, YAP was phosphorylated to be inactivated via Hippo core kinase cassette consisting of MST1/2 and LATS1/2 [14, 82-84].”
InfluentialThe tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis
Yabuta, N., Mukai, S., Okada, N., Aylon, Y., & Nojima, H. (2011) · Cell Cycle · doi:10.4161/cc.10.16.16873 · Cited by 74
“Lats2 is also regulated through phosphorylation by several upstream kinases, including Aurora A, which is activated in response to mitotic signals;(22) the checkpoint kinase Chk1, which is activated in response t UV-induced DNA damage(25) and the mammalian Ste20-like kinases Mst1 and 2, which are activated through the…”
BackgroundMolecular mechanism of size control in development and human diseases
Yang, X., & Xu, T. (2011) · Cell Research · doi:10.1038/cr.2011.63 · Cited by 74
Death pathways triggered by activated Ras in cancer cells
Jean, H. O. (2010) · Frontiers in bioscience · doi:10.2741/3814 · Cited by 73
“Based on other studies showing that the stimulation of MST1 may activate the kinases LATs1 and LATs2, which leads to down-regulation of the anti-apoptotic Bcl-2 (155,156), Vos et al.”
BackgroundLiu, Z., Wei, Y., Zhang, L., Yee, P. P., Johnson, M., Zhang, X., Gulley, M., Atkinson, J. M., Trebak, M., Wang, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0425-7 · Cited by 72
Gao, Y., Yi, J., Zhang, K., Bai, F., Feng, B., Wang, R., Chu, X., Chen, L., & Song, H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0622-1 · Cited by 72
“Analogously, Mitamura T et al. validated that miR-31 could suppress the luciferase activity of mRNA combined with the LATS2 3′-UTR and consequently promoted the translocation of YAP1 [45].”
BackgroundHippo signaling in mammalian stem cells
Tremblay, A., & Camargo, F. D. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.08.001 · Cited by 70
Roles of the H ippo pathway in lung development and tumorigenesis
Yeung, B., Yu, J., & Yang, X. (2015) · International Journal of Cancer · doi:10.1002/ijc.29457 · Cited by 68
“1; please note that AMOT can both increase and decrease Hippo signaling)(27-34).”
BackgroundPARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction
Lv, X., Liu, C., Wang, Z., Sun, Y., Xiong, Y., Lei, Q., & Guan, K. (2015) · EMBO Reports · doi:10.15252/embr.201439951 · Cited by 68
Metadata
- Authors
- Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W.
- Affiliations
- Max Planck Society (DE)
- Corresponding author
- Silljé, Herman H W
- Venue
- Oncogene
- Published
- 2005-01-31
- Volume
- 24
- Issue
- 12
- Pages
- 2076-2086
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2105193974
- Cited by
- 584
- References
- 42
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 41 · 2023: 19 · 2022: 37 · 2021: 39 · 2020: 40 · 2019: 36 · 2018: 39 · 2017: 26 · 2016: 36 · 2015: 35 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Croucher Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- MST2, LATS1, LATS2, Ste20-like kinase, Hippo signaling pathway, Warts kinase, kinase activation, phosphorylation sites, catalytic domain, tumor suppressor kinase, cell cycle regulation, apoptosis
- MeSH terms
- Serine-Threonine Kinase 3, Hippo Kinases, Amino Acid Sequence, Animals, Cell Line, Drosophila melanogaster, Gene Expression Regulation, HeLa Cells, Humans, Kidney, Peptide Fragments, Genes, Tumor Suppressor, Protein Serine-Threonine Kinases, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.